US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Monkeypox Concept

1,399.83

-4.1056-0.29%

Number of Gainers:2

Number of Losers:9

Number of Flat:1

PE:- -

High:1,409.65

Open:1,403.41

Low:1,384.46

Close:1,403.94

Loading ...

Gilead Sciences (GILD) Stock Moves -0.74%: What You Should Know

Siga Technologies Inc. (SIGA) Stock Moves -1.82%: What You Should Know

Is Gilead Sciences Inc. (NASDAQ:GILD) the Most Undervalued Quality Stock to Buy Now?

BRIEF-Tonix Pharmaceuticals Announces Oral Presentation And Panel Participation At The World Vaccine Congress Washington 2025

Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025

THOMSON REUTERS

Analysts Are Bullish on These Healthcare Stocks: GeoVax Labs (GOVX), Tango Therapeutics (TNGX)

Roth says BARDA stopping funding for GeoVax COVID trial similar to peers

GeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall

MT Newswires Live

Crude Oil Moves Lower; Citigroup Posts Upbeat Results

GeoVax to Present Clinical Data at Upcoming April Industry Events

GeoVax Labs price target lowered to $8.50 from $15 at Alliance Global Partners

Presenting on Emerging Growth Conference 81 Day 1 on April 16; Register to live stream

BRIEF-GeoVax Labs Got Written Notification From Advanced Technology International

BUZZ-GeoVax tumbles as HHS ends mid-stage COVID vaccine trial

GeoVax Labs- Notice Indicated That Barda Terminated Contract for Convenience to Government - SEC Filing

THOMSON REUTERS

GeoVax Labs- Notice to Stop Work on Phase 2B Study to Evaluate Geo-Cm04s1 Covid-19 Vaccine Trial - SEC Filing

THOMSON REUTERS

GeoVax Labs: on April 11, Got Written Notification From Advanced Technology International

THOMSON REUTERS

Is Viatris Inc. (VTRS) The Top Healthcare Stock to Buy According to Billionaire David Einhorn?

BRIEF-Viatris Appoints Hemanth J. Varghese As Chief Strategy Officer

Press Release: Viatris Appoints Hemanth J. Varghese as Chief Strategy Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4583/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4583","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":1399.831,"timestamp":1745265599999,"preClose":1403.9366,"halted":0,"volume":21354122,"delay":0,"changeRate":-0.002924,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-4.105591,"latestTime":"04-21 16:00:00 EDT","open":1403.4071,"high":1409.6544,"low":1384.4579,"amount":1017835354.827261,"amplitude":0.017947,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.482004,"peRate":759.167081,"turnoverRate":0.007859,"increases":2,"decrements":9,"flats":0,"marketCap":157928380119.5,"floatMarketCap":157302737571.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","high":1409.6544,"amplitude":0.017947,"preClose":1403.9366,"low":1384.4579,"pbRate":"3.482004","latestPrice":1399.831,"volume":21354122,"delay":0,"open":1403.4071,"prevYearClose":1284.7982,"prevWeekClose":1403.9366,"prevMonthClose":1502.9401,"prevQuarterClose":1502.9401,"fiveDayClose":1393.7178,"twentyDayClose":1452.8525,"sixtyDayClose":1279.2769,"secType":"PLATE","market":"US","turnoverRate":0.007859,"peRate":759.167081,"marketCap":157928380119.5,"floatMarketCap":157302737571.5,"timestamp":1745265599999,"nameCN":"Monkeypox Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4583\",,,,undefined,":{"bkCode":"BK4583","up":2,"down":9,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4583\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528578599","title":"Gilead Sciences (GILD) Stock Moves -0.74%: What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2528578599","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528578599?lang=en_us&edition=fundamental","pubTime":"2025-04-17 06:00","pubTimestamp":1744840815,"startTime":"0","endTime":"0","summary":"The most recent trading session ended with Gilead Sciences  standing at $104.90, reflecting a -0.74% shift from the previouse trading day's closing. This change was narrower than the S&P 500's daily loss of 2.24%. Meanwhile, the Dow experienced a drop of 1.73%, and the technology-dominated Nasdaq saw a decrease of 3.07%.Shares of the HIV and hepatitis C drugmaker have depreciated by 4.13% over the course of the past month, outperforming the Medical sector's loss of 7.47% and the S&P 500's loss of 4.17%.Market participants will be closely following the financial results of Gilead Sciences in its upcoming release. The company plans to announce its earnings on April 24, 2025. In that report, analysts expect Gilead Sciences to post earnings of $1.73 per share. This would mark year-over-year growth of 231.06%. At the same time, our most recent consensus estimate is projecting a revenue of $6.83 billion, reflecting a 2.18% rise from the equivalent quarter last year.The Zacks Industry Rank ga","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-sciences-gild-stock-moves-220015275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0234570918.USD","BK4139","IE00BSNM7G36.USD","LU0289739699.SGD","BK4568","LU1839511570.USD","LU1585245621.USD","IE00B19Z3B42.SGD","IE0002270589.USD","BK4588","IE00B19Z3581.USD","LU0058720904.USD","IE00B7SZLL34.SGD","BK4550","IE00B3T34201.USD","BK4585","BK4566","LU0889565916.HKD","BK4532","BK4578","GILD","BK4583","LU1066051498.USD","LU0109394709.USD","LU1066053197.SGD","LU1430594728.SGD","IE00BZ1G4Q59.USD","LU2087621335.USD","LU1571399168.USD","LU2468319806.SGD","IE00BKVL7J92.USD","LU0320765992.SGD","LU2089984988.USD"],"gpt_icon":0},{"id":"2528320000","title":"Siga Technologies Inc. (SIGA) Stock Moves -1.82%: What You Should Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2528320000","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528320000?lang=en_us&edition=fundamental","pubTime":"2025-04-17 05:45","pubTimestamp":1744839916,"startTime":"0","endTime":"0","summary":"Siga Technologies Inc.  closed at $5.93 in the latest trading session, marking a -1.82% move from the prior day. This change was narrower than the S&P 500's 2.24% loss on the day. Elsewhere, the Dow saw a downswing of 1.73%, while the tech-heavy Nasdaq depreciated by 3.07%.Heading into today, shares of the company had gained 4.86% over the past month, outpacing the Medical sector's loss of 7.47% and the S&P 500's loss of 4.17% in that time.The investment community will be closely monitoring the performance of Siga Technologies Inc. in its forthcoming earnings report.Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Siga Technologies Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the company's business operations and its ability to generate profits.In terms of valuation, Siga Technologies Inc. is presently being traded","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/siga-technologies-inc-siga-stock-214516501.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4583","SIGA"],"gpt_icon":0},{"id":"2527324143","title":"Is Gilead Sciences Inc. (NASDAQ:GILD) the Most Undervalued Quality Stock to Buy Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527324143","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527324143?lang=en_us&edition=fundamental","pubTime":"2025-04-16 21:54","pubTimestamp":1744811662,"startTime":"0","endTime":"0","summary":"We recently published a list of the 11 Most Undervalued Quality Stocks to Buy Now. In this article, we are going to take a look at where Gilead Sciences Inc.  stands against other undervalued quality stocks to buy now.On February 24, Kayne Anderson Rudnick chief market strategist Julie Biel joined ‘The Exchange’ on CNBC to discuss her thoughts on how good quality companies can ride out turbulence in the market. Just like Warren Buffett and Charlie Munger, Biel also suggests inaction as an investment principle and believes that holding high-quality companies can help investors deal with market volatility. She emphasized conviction in investing instead of impulsive decision-making. Biel also noted the general resilience of the US economy, which mainly comes from a robust jobs market as it fuels the consumer-driven economy. She also expressed unease over the limited tools available to address a potential recession that could come from high levels of deficit spending. She thinks inefficien","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-sciences-inc-nasdaq-gild-135422051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","IE0002270589.USD","IE00B64PRP62.GBP","BK4568","LU0889565916.HKD","LU1571399168.USD","LU1839511570.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","IE00BSNM7G36.USD","QID","SQQQ","BK4588","NVIW.SI","NQmain","IE00B19Z3581.USD","BK4112","IE00BKVL7J92.USD","USAW.SI","BK4139","BK4583","LU0058720904.USD","LU1066053197.SGD","QLD",".IXIC","BK4578","LU0320765992.SGD","LU0234570918.USD","NDAQ","TSYW.SI","LU2210150020.SGD","LU2468319806.SGD","LU2095319765.USD","BK4532","GILD","BK4550","LU1430594728.SGD","MNQmain","LU2210149790.SGD","USJW.SI","LU0109394709.USD","IE00B7SZLL34.SGD","PSQ","IE00B19Z3B42.SGD","LU1066051498.USD","TQQQ","LU0289739699.SGD","BK4566","IE00B3T34201.USD"],"gpt_icon":1},{"id":"2527129240","title":"BRIEF-Tonix Pharmaceuticals Announces Oral Presentation And Panel Participation At The World Vaccine Congress Washington 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2527129240","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527129240?lang=en_us&edition=fundamental","pubTime":"2025-04-16 19:18","pubTimestamp":1744802322,"startTime":"0","endTime":"0","summary":"BRIEF-Tonix Pharmaceuticals Announces Oral Presentation And Panel Participation At The World Vaccine Congress Washington 2025April 16 (Reuters) - Tonix Pharmaceuticals Holding Corp TNXP.O:TONIX PHARMA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nTUAWMVJQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","TNXP"],"gpt_icon":1},{"id":"2527291780","title":"Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2527291780","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527291780?lang=en_us&edition=fundamental","pubTime":"2025-04-16 19:00","pubTimestamp":1744801202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nTUAWMVJQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","TNXP","BK4139"],"gpt_icon":0},{"id":"2527259984","title":"Analysts Are Bullish on These Healthcare Stocks: GeoVax Labs (GOVX), Tango Therapeutics (TNGX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2527259984","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527259984?lang=en_us&edition=fundamental","pubTime":"2025-04-16 01:20","pubTimestamp":1744737614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on GeoVax Labs (GOVX – Research Report), Tango Therapeu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-geovax-labs-govx-tango-therapeutics-tngx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-geovax-labs-govx-tango-therapeutics-tngx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GOVX","HCSG","BK4139","TNGX","BK4137","BK4583"],"gpt_icon":0},{"id":"2527425961","title":"Roth says BARDA stopping funding for GeoVax COVID trial similar to peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2527425961","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527425961?lang=en_us&edition=fundamental","pubTime":"2025-04-16 01:15","pubTimestamp":1744737309,"startTime":"0","endTime":"0","summary":"Roth Capital lowered the firm’s price target on GeoVax Labs (GOVX) to $18 from $20 and keeps a Buy rating on the shares after the company released ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roth-says-barda-stopping-funding-for-geovax-covid-trial-similar-to-peers?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roth-says-barda-stopping-funding-for-geovax-covid-trial-similar-to-peers?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GOVX","BK4139","BK4583"],"gpt_icon":0},{"id":"2527644764","title":"GeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2527644764","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527644764?lang=en_us&edition=fundamental","pubTime":"2025-04-16 00:12","pubTimestamp":1744733524,"startTime":"0","endTime":"0","summary":"GeoVax Labs  said late Monday Advanced Technology International notified the company to stop work on its phase 2b study to evaluate the GEO-CM04S1 COVID-19 vaccine.Advanced Technology is the Rapid Response Partnership Vehicle's consortium management firm funded by the Biomedical Advanced Research and Development Authority of the US Department of Health and Human Services, according to its regulatory filing.The notice indicated that BARDA decided to terminate the contract for convenience to the government, the filing said.Shares of the company were down over 21% in Tuesday trading.Price: 0.84, Change: -0.23, Percent Change: -21.50","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["GOVX","BK4139","BK4583","BNTX"],"gpt_icon":0},{"id":"2527447547","title":"Crude Oil Moves Lower; Citigroup Posts Upbeat Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2527447547","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527447547?lang=en_us&edition=fundamental","pubTime":"2025-04-16 00:10","pubTimestamp":1744733440,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/04/44819308/dow-gains-100-points-citigroup-posts-upbeat-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNQmain","LU2456880835.USD","SQQQ",".IXIC","LU0162691827.USD","QID","LU0098860793.USD","TSYW.SI","USJW.SI","BK4588","LU0106831901.USD","SKYE","LU2462157665.USD","BK4504","MURA","BK4609","LU0648001328.SGD","BK4023","LU2360032135.SGD","LU0170899867.USD","IE00BSNM7G36.USD","BK4585","NVIW.SI","APLD","QLD","PSQ","BK4583","TQQQ","LU0130102774.USD","RZLV","LU2417539215.USD","LU1668664300.SGD","USAW.SI","BK4608","LU1201861249.SGD","LU1267930227.SGD","LU0320765646.SGD","BK4116","BK4566","LU0128525689.USD","BK4534","C","GOVX","SPRB","LU1791807156.HKD","LU0052756011.USD","NQmain","LU0072461881.USD","LU2125154935.USD"],"gpt_icon":1},{"id":"2527941465","title":"GeoVax to Present Clinical Data at Upcoming April Industry Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2527941465","media":"NewMediaWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527941465?lang=en_us&edition=fundamental","pubTime":"2025-04-15 21:00","pubTimestamp":1744722000,"startTime":"0","endTime":"0","summary":"Data to be Presented on the Company's GEO-CM04S1 and Gedeptin Programs. ATLANTA, GA - April 15, 2025  - GeoVax Labs, Inc. , a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that members of its senior management team and other scientific representatives will participate in two upcoming industry events during April. Event details are as follows:. World Vaccine Congress, April 22-24, 2025, Washington, DC. Phase 2b Study Results That Evaluated and Compared GeoVax's Multi-Antigen, Vaccine Candidate  to an Approved Vaccine Against COVID-19. Don J. Diamond, PhD, Director, Division of Vaccine Research & Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center. Viral-Vectored, Gene-Directed Prodrug Therapy  in Needle-Accessible Solid Tumors","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/geovax-present-clinical-data-upcoming-130000897.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4535","BK4551","BK4583","R","BK4568","BK4588","GOVXW","GOVX","BK4022","BK4585","BK4139","BK4232","BNTX","BK4548"],"gpt_icon":0},{"id":"2527917954","title":"GeoVax Labs price target lowered to $8.50 from $15 at Alliance Global Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2527917954","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527917954?lang=en_us&edition=fundamental","pubTime":"2025-04-15 19:12","pubTimestamp":1744715536,"startTime":"0","endTime":"0","summary":"Alliance Global Partners lowered the firm’s price target on GeoVax Labs (GOVX) to $8.50 from $15 and keeps a Buy rating on the shares. The target c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/geovax-labs-price-target-lowered-to-8-50-from-15-at-alliance-global-partners?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/geovax-labs-price-target-lowered-to-8-50-from-15-at-alliance-global-partners?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4583","BK4139","GOVX"],"gpt_icon":0},{"id":"2527549911","title":"Presenting on Emerging Growth Conference 81 Day 1 on April 16; Register to live stream","url":"https://stock-news.laohu8.com/highlight/detail?id=2527549911","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527549911?lang=en_us&edition=fundamental","pubTime":"2025-04-15 19:00","pubTimestamp":1744714800,"startTime":"0","endTime":"0","summary":"MIAMI, April 15, 2025  -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 81th Emerging Growth Conference on April 16 & 17, 2025.The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/presenting-emerging-growth-conference-81-110000154.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OMEX","GOVX","BK4017","BK4583","BK4139","HGRAF","OPWEF","PSQ","EVFM","PSQH","USEG","NVA.AU","BK4584","USAW.SI","QID","BK4077","BK4162","NVA","BK4196","UURAF","ASBP","CLNN","TQQQ","NVAWW","SQQQ","TSYW.SI","XXII","BK4124","BK4075","URG","BNZI","BK4007","BK4137","NVIW.SI","CUAUF","BK4168","MNQmain","BK4135","ELRRF","SBC",".IXIC","BENF","BK4213","NQmain","QLD","BK4023","SEVCF","USJW.SI","CIA","BIXT"],"gpt_icon":1},{"id":"2527140948","title":"BRIEF-GeoVax Labs Got Written Notification From Advanced Technology International","url":"https://stock-news.laohu8.com/highlight/detail?id=2527140948","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527140948?lang=en_us&edition=fundamental","pubTime":"2025-04-15 05:38","pubTimestamp":1744666738,"startTime":"0","endTime":"0","summary":"BRIEF-GeoVax Labs Got Written Notification From Advanced Technology InternationalApril 14 (Reuters) - GeoVax Labs Inc GOVX.O:GEOVAX LABS: ON APRIL 11, GOT WRITTEN NOTIFICATION FROM ADVANCED TECHNOLOGY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QS1YL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","GOVX","BK4139"],"gpt_icon":1},{"id":"2527142345","title":"BUZZ-GeoVax tumbles as HHS ends mid-stage COVID vaccine trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2527142345","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527142345?lang=en_us&edition=fundamental","pubTime":"2025-04-15 05:02","pubTimestamp":1744664526,"startTime":"0","endTime":"0","summary":"BUZZ-GeoVax tumbles as HHS ends mid-stage COVID vaccine trial** Shares of drug developer GeoVax Labs GOVX.O fall 16% to 89 cents in extended trading** The U.S. Department of Health and Human Services has decided to terminate GeoVax's COVID-19 vaccine project contract — SEC filing** The reason for the termination is stated as \"convenience to the government\"** GeoVax received a stop-work notice from Advanced Technology International  directing them to halt all activities related to the project** The project was funded by the Biomedical Advanced Research and Development Authority , a division of HHS** The COVID-19 vaccine was in the mid-stage trial** As of last close, stock fell 5.7% YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nL4N3QS1KR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","GOVX","BK4139"],"gpt_icon":0},{"id":"2527914188","title":"GeoVax Labs- Notice Indicated That Barda Terminated Contract for Convenience to Government  - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2527914188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527914188?lang=en_us&edition=fundamental","pubTime":"2025-04-15 04:30","pubTimestamp":1744662648,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QS1YL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","GOVX","BK4139"],"gpt_icon":0},{"id":"2527149094","title":"GeoVax Labs- Notice to Stop Work on Phase 2B Study to Evaluate Geo-Cm04s1 Covid-19 Vaccine Trial - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2527149094","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527149094?lang=en_us&edition=fundamental","pubTime":"2025-04-15 04:30","pubTimestamp":1744662648,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QS1YL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GOVX","BK4583"],"gpt_icon":0},{"id":"2527149035","title":"GeoVax Labs: on April 11, Got Written Notification From Advanced Technology International","url":"https://stock-news.laohu8.com/highlight/detail?id=2527149035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527149035?lang=en_us&edition=fundamental","pubTime":"2025-04-15 04:30","pubTimestamp":1744662648,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QS1YL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GOVX","BK4139","BK4583"],"gpt_icon":0},{"id":"2527169285","title":"Is Viatris Inc. (VTRS) The Top Healthcare Stock to Buy According to Billionaire David Einhorn?","url":"https://stock-news.laohu8.com/highlight/detail?id=2527169285","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527169285?lang=en_us&edition=fundamental","pubTime":"2025-04-14 21:06","pubTimestamp":1744636014,"startTime":"0","endTime":"0","summary":"We recently published a list of Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn. In this article, we are going to take a look at where Viatris Inc.  stands against other top healthcare stocks to buy according to billionaire David Einhorn.Wall Street has come down crashing on President Donald Trump’s sweeping tariffs, raising the risk of a trade war that could push the global economy into recession. Major equity indexes have recorded their worst days in years, with the S&P 500 slipping back into correction territory. Amid the bloodbath, the focus is slowly turning to defensive sectors poised to shrug off the long-term effects of the trade war.“We have reached the ‘Fartcoin’ stage of the market cycle,” Einhorn wrote in an investor letter obtained by CNBC. “Other than trading and speculation, it serves no other obvious purpose and fulfills no need that is not served elsewhere.”“Within the equity market, we continue to recommend that investors own the health care sect","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viatris-inc-vtrs-top-healthcare-130654370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SH","BK4504","LU1839511570.USD","ESmain","BK4581","USJW.SI","VTRS","BK4583",".IXIC","SPY","SSO","OEF","BK4534","BK4550","MNQmain","GLRE","QID","BK4585","QLD","TQQQ","BK4137","SDS","BK4019","BK4559","IVV","TSYW.SI","VOO","USAW.SI","SQQQ","PSQ","NQmain",".SPX","LU2087621335.USD","HCSG","OEX","BK4007","NVIW.SI","BK4588"],"gpt_icon":1},{"id":"2527538271","title":"BRIEF-Viatris Appoints Hemanth J. Varghese As Chief Strategy Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2527538271","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527538271?lang=en_us&edition=fundamental","pubTime":"2025-04-14 19:07","pubTimestamp":1744628822,"startTime":"0","endTime":"0","summary":"BRIEF-Viatris Appoints Hemanth J. Varghese As Chief Strategy OfficerApril 14 (Reuters) - Viatris Inc VTRS.O:VIATRIS APPOINTS HEMANTH J. VARGHESE AS CHIEF STRATEGY OFFICERSource text: ID:nPn4TWXC7aFurther company coverage: VTRS.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nTUA6KJQZL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4588","BK4585","LU2087621335.USD","BK4007","VTRS","LU1839511570.USD"],"gpt_icon":0},{"id":"2527130171","title":"Press Release: Viatris Appoints Hemanth J. Varghese as Chief Strategy Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2527130171","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527130171?lang=en_us&edition=fundamental","pubTime":"2025-04-14 18:59","pubTimestamp":1744628340,"startTime":"0","endTime":"0","summary":"PITTSBURGH, April 14, 2025 /PRNewswire/ -- Viatris Inc.  today announced that Hemanth J. Varghese has joined the Company as Chief Strategy Officer. Varghese will be a member of the Company's Executive Leadership Team.Varghese is an accomplished healthcare leader with more than 20 years of strategy, operations and corporate development experience. He brings broad experience leading growth initiatives and strategic transformations in diversified multi-national healthcare companies.\"We are excited to welcome Hemanth to Viatris in the role of Chief Strategy Officer,\" said Scott A. Smith, CEO, Viatris. \"Hemanth adds another valuable perspective to our Executive Leadership Team. I believe his skills and expertise will be integral as we continue to shape our company for growth in 2026 and beyond.\". \"I am honored to be joining Viatris at such a transformative time for the company,\" said Varghese. \"I'm looking forward to partnering with Scott, the Executive Leadership Team and others across the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","LU1839511570.USD","VTRS","BK4588","BK4583","STRK","BK4007","BK4516","LU2087621335.USD","BK4595","BK4585","BK4596","BK4600"],"gpt_icon":1}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":85,"code":"91000000","status":"200"}]}}